M. Delatorre et al., EXPRESSION OF THE CD44 GLYCOPROTEIN (LYMPHOCYTE-HOMING RECEPTOR) IN UNTREATED HUMAN BREAST-CANCER AND ITS RELATIONSHIP TO PROGNOSTIC MARKERS, Anticancer research, 15(6B), 1995, pp. 2791-2795
CD44 is a cell surface glycoprotein which has been suggested to be ass
ociated with aggressive histological features in breast cancer (BC). I
t has also been implicated in conferring metastatic potential to rat c
at-cinema cells. The aim of this study was to deter-mine the potential
value prognostic/metastatic marker in BC by means of immunohistochemi
stry. The expression of the CD44 glycoprotein was investigated in tumo
urs from 52 untreated female patients with BC, using the monoclonal an
tibody A3D8. 10 samples of normal breast tissue were randomly obtained
and also investigated with respect to CD44 expression. DNA ploidy, th
e S-phase function (SPF) and oestrogen-(OR) and progesterone-receptor.
(PgR) contents in the tumours were determined and together with the p
rognostic markers of age, age tumour size, tumour grade and lymph none
status, correlated with CD44 expression in BC. Also, the distribution
of CD44 tumour cell expression was compared with expression of the pe
rmeability drug resistance glycoprotein (P-gp) in this material. Expre
ssion of CD44 on carcinoma cells was observed in 21/52 cases (40%). Ca
pillary endothelial reactivity of the tumours occurred in 42 cases (80
%). Non-neoplastic epithelial breast tissue was positive in 2/10 (20%)
samples and capillary vessels in 7/10 (70%). Carcinoma CD44 cell expr
ession was not associated with age, tumour size, tumour grade, DNA plo
idy, SPF, hormone-receptor contents or lymph node metastases. There wa
s a statistical correlation between CD44 and P-gp expression in breast
carcinoma cells which may suggest a connection between adhesion molec
ules and drug resistance. These findings do not support an association
between CD44 expression and adverse prognostic features or lymph node
metastases in BC. Capillary CD44 staining was a common feature in BC.
There appeared to be an upward regulation in CD44 expression in BC co
mpared with the normal breast tissue.